The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
Clinical trial NCT01676116 · COMPLETED
Trial details
- NCT number
- NCT01676116
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-29
- Primary completion
- 2014-03-11
- Enrollment
- 438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.